Stephen Dyer is the managing member of SRD Capital Management, LLC which he established in September 2006 after 22 years on Wall Street including 18 years at UBS Financial Services (and its predecessor Paine Webber Inc). Steve currently serves as the Chairman of Jumpstart NJ Angel Network, a private forty member lead angel investor group that invests in early stage technology companies in the Mid-Atlantic region. Steve joined Jumpstart in 2007 and was asked to join the Board of Directors of Jumpstart in 2009. He is an investor in several early stage companies and is also an Advisor or on the Board of Directors of several of the companies. In January 2011, Steve was asked to join Rutgers University newly launched “CEO-in-Residence” program to assist the university in reviewing its intellectual property and help decide whether specific innovations can be commercialized or form the basis for start-ups. Prior to SRD, Steve worked in the partnership product area for most of his UBS career. Steve received his B.S. degree (magna cum laude) in Accounting in 1981 from Boston College and his MBA from Indiana University in December 1984. He is a Certified Public Accountant having started his career in the audit group of Ernst & Young predecessor Arthur Young & Company in 1981.
Andrew joined Lingraphica as the CEO in 2003. Lingraphica makes speech-generating devices and therapy software for adults with language deficits due to stroke. Previously, he served as Senior Vice President of Product Development at Juice Software, an enterprise software company. Previous to that he was Vice President of Product Development at iFace, a voice-over-Internet company, and Vice President of Product and Business Development at ALK Associates, a pioneer in the computer mapping, routing, and logistics industry. He also spent ten years in the music business founding a band, recording studio and record label. Andrew graduated from Princeton University and holds an MS in Computer Science from Rutgers University.
Shahram Hejazi is a life science investor/entrepreneur with executive general management experience in early-stage ventures and large global companies. Over his 20+ year career, Shahram has founded and/or directed the growth of more than a dozen startup companies. As a Venture Partner with BioAdvance, where he leads investments in medical technologies, research tools and health IT, Shahram serves on the Board of 6 portfolio companies. He is also the founder and CEO of Optimeos Life Sciences, and the current James Wei Visiting Professor of Entrepreneurship at Princeton University. Before this, he was the President of Kodak's life science division, where he had global responsibility for R&D, manufacturing, operations, sales, marketing and service. Before Kodak, he was the CEO of Zargis Medical Corp. (a Siemens spinoff) where he led the company from raising capital and the technology development to completion of several clinical trials, and successful FDA regulatory approval. Prior to Zargis, Shahram was the Head of the Strategic Business Development at Siemens medical and held R&D management positions at Kodak and IBM (Yorktown Heights). Shahram has a PhD in electrical engineering with emphasis in biophysics (SUNY) and an executive business education (Stanford).
Simon is a serial entrepreneur within the enterprise software sector with a track record of founding and growing businesses. Since starting his career with Accenture, he has worked for high-growth organizations in Europe, SE Asia as well as the US, including CEO of ROC Americas Inc., and COO of Axon Solutions. Simon is a hands-on manager with experience of technology, operations and business development, as well as three acquisitions and an IPO. As a member of the New York Angels, he is closely involved with a number of local start-ups, as investor, advisor and junior developer. Simon is a graduate of Imperial College, London, and a Harvard Business School alumnus. He lives in Princeton with his wife Clare, and their three children.